Iroko Pharmaceuticals, LLC – Trademark Portfolio
Entity Type: 16
Iroko Pharmaceuticals, LLC holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INDOCIN. The owner is based in Philadelphia, PA.
150 Rouse Boulevard
One Kew Place
Philadelphia, PA 19112
Showing of trademarks Trademarks
Trademark Classifications
Iroko Pharmaceuticals, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Iroko Pharmaceuticals, LLC have?
Iroko Pharmaceuticals, LLC has 18 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 8 cancelled.
What trademark classes does Iroko Pharmaceuticals, LLC file in?
Iroko Pharmaceuticals, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Iroko Pharmaceuticals, LLC's most well-known trademarks?
Iroko Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as INDOCIN. These are among 1 currently registered trademark in the portfolio.
What is Iroko Pharmaceuticals, LLC's trademark registration success rate?
Iroko Pharmaceuticals, LLC has a 6% trademark registration rate, with 1 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.